OXFORD TEXTBOOK OF PSORIATIC ARTHRITIS

• Introduction
1: Introduction to Psoriatic Arthritis, Dafna Gladman and Oliver FitzGerald
• Epidemiology
2: Epidemiology of Psoriasis, Joel Gelfand and Junko Takeshita
3: Epidemiology of Psoriatic Arthritis, Elaine Husni and Madonna Michael
• Pathogenesis
4: Overview of Psoriatic Arthritis Pathogenesis, Kurt De Vlam
5: Genetics of Psoriasis, Philip E. Stuart, Lam C. Tsoi, Caely A. Hambro, and James T. Elder
6: Genetics of Psoriatic Arthritis, Robert Winchester and Proton Rahman
7: Immunology and Cytokine Pathways, Bruce Kirkham
8: Mechanisms of bone destruction and proliferation, Rik Lories
• Clinical features
9: Psoriasis and Nail, Cheryl F. Rosen and Brian Kirby
10: Peripheral arthritis, Raffaele Scarpa, Francesco Caso, Luisa Costa, Rosario Peluso, Nicola Matteo Dario Di Minno, and Antonio Del Puente
11: Enthesitis, Juan D. Cañete and Julio Ramírez
12: Dactylitis, Ignazio Olivieri, Enrico Scarano, Salvatore D'Angelo, Carlo Palazzi, and Angela Padula
13: Axial disease, Ennio Lubrano
14: Extra-articular, extra-skin disease, Filip Van den Bosch
15: Co-morbidities, Muhammad Haroon
• Imaging
16: Plain radiography, Neil McHugh and William Tillett
17: Ultrasound, Gurjit Kaeley
18: MRI, Dennis McGonagle and Iris Eshed
19: MicroCT, Georg Schett and Camille Figueiredo
• Diagnosis and classification
20: Diagnosis and classification criteria, Laura Coates and William Taylor
• Outcome and biomarkers
21: Clinical course and outcome, Lihi Eder
22: Biomarkers of psoriatic arthritis outcome, Vinod Chandran and Katerina Oikonomopoulou
• Domains, instruments, and composite scores
23: Domains and instruments, Alberto Cauli
24: Patient-related outcome measures, Laure Gossec, Maarten de Wit, and Tania Gudu
25: Composite scores, Philip Helliwell
• Treatment
26: Psoriasis treatment, Alice Gottlieb, Ami Saraiya, and Deep Joshipura
27: Approach to management and symptomatic (including non-pharmacologic) management of PsA, Enrique Soriano and Laura Acosta Felquer
28: Synthetic DMARDS, Frank Behrens, Michaela Koehm, and Michael J. Pamham
29: Biologic DMARDS (TNFi), Arthur Kavanaugh and Tristan Boyd
30: Non-TNF Biologic DMARDS, Philip Mease
31: Treatment algorithm and treat to target, Laura Coates, Arthur Kavanaugh, and Christopher Ritchlin
• Future directions
32: Future directions, Dafna Gladman and Oliver FitzGerald

Psoriatic arthritis, or PsA, is now acknowledged the second most prevalent and important inflammatory arthropathy worldwide. The addition of this new textbook on PsA is a fitting and important inclusion to the Oxford Textbooks in Rheumatology series, written to reflect the significant advances in the field in recent years.
With the recent advances in the understanding of pathogenesis, and the development of novel therapies, the Oxford Textbook of Psoriatic Arthritis provides a comprehensive overview of the disease. Each chapter is written by leading clinicians and scientists in the field of psoriatic arthritis, to provide a contemporary view of PsA, and a look into the future directions of research. Covering everything from epidemiology and diagnosis to genetics and pathology, detailed sections on treatment and outcomes provide an invaluable resource for the clinician. The book is also highly illustrated with both clinical images such as x-rays and histological photographs to aid clinical knowledge, and diagrams of the immunology and genetics that underlie the disease.
Practical and all-inclusive, with summary boxes to distil the most important information, the Oxford Textbook of Psoriatic Arthritis will prove an invaluable resource for rheumatologists, dermatologists, trainees, and all members of the multidisciplinary team who are interested in recent advances in PsA.

Features
• A comprehensive reference to this rapidly evolving field
• Covers significant recent advances in the field, including the development of novel therapies, advances in the understanding of pathogenesis, and the future directions for research
• Highly illustrated, with clinical and histological images to aid understanding and diagnosis, and annotated diagrams to provide a solid background in the science behind the disease
• Written by internationally recognised leading experts in the field, providing a contemporary overview of the disease

Authors
• Professor Oliver FitzGerald is a consultant rheumatologist at St Vincent's University Hospital, and the Newman Clinical Research Professor at the Conway Institute of Biomolecular and Biomedical Research at University College Dublin. He has published over 280 peer-reviewed papers, and his main research interests include the clinical and therapeutic studies of psoriatic arthritis, the development of novel imaging techniques for measuring synovial or entheseal inflammation, and studies of gene and protein expression in diseased tissue. He also serves as a council member for the Group for Research and Assessment is Psoriasis and Psoriatic Arthritis (GRAPPA), and is developing a longitudinal study of soluble biomarkers with the OMERACT group.
• Dr Dafna Gladman is a senior scientist at the Toronto Western Research Institute, University Health Network and Professor of Medicine at the University of Toronto. She heads the Centre for Prognosis in Rheumatic Diseases, which currently studies areas including Systemic Lupus Erythematosus and Psoriatic Arthritis, and is co-director of the Psoriatic Arthritis at the UHN Arthritis Program. She has over 520 peer-reviewed publications, including important contributions to the field such as identifying predictors for disease progression and mortality. She received the Verna Wright Prize for outstanding contributions to the field of Psoriatic Arthritis by the International psoriatic Arthritis Group.